Clinical Trial Update: Oxaliplatin in Esophagus Cancer (Advanced) 1st Line [Phase 2]

View source ↗

Summary

Sanofi-sponsored Phase 2 trial of oxaliplatin as first-line therapy for advanced esophageal cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Esophageal Neoplasms | Phase 2 | Status: COMPLETED